Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Oct 6, 2022

Keywords

ClinConnect Summary

This clinical trial is studying whether a nutritional supplement made from mother-of-pearl can help prevent osteoporosis in post-menopausal women. Osteoporosis is a condition that weakens bones, making them more likely to break, which can lead to serious health issues and loss of independence. The study aims to find out if this natural supplement can be a safe alternative to hormone replacement therapy, which is no longer recommended for many women due to potential side effects.

To participate in the trial, women aged 50 to 65 who have been through menopause and are at risk for osteoporosis may be eligible. They should have a bone density score (T-score) between -1 and -3 and should not have a history of fractures. However, women with certain medical conditions, such as those affecting bone health or kidney stones, cannot join. Participants can expect to take the supplement and be monitored for its effects on their bone health. This study is important because it explores new ways to help women maintain strong bones after menopause.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Post-menopausal women (50-65y) with risk of becoming osteoporotic
• • T-score between -1 and -3
• • Absence of fragility fractures history
• Exclusion Criteria:
• • absence of parathyroid glands (phospho-calcic regulation)
• • presence of kidney stones
• • patients who follow a treatment that could interfere with bone metabolism (corticotherapy, menopausal hormonal therapy, anti-oestrogen treatment, non-controlled hyperthyroiditis, hyper- and hypothyroiditis)
• • bone diseases (Paget'disease, osteomalacia)
• • chronic alcoholism